Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

——2022年第24期 ——

本期文献

Inhibiting BDNF/TrkB.T1 receptor improves resiniferatoxin-induced postherpetic neuralgia through decreasing ASIC3 signaling in dorsal root ganglia

Journal: Journal of Neuroinflammation

Authors: Xiang Wei, et al.

Year/Issue/Volume:2021 Apr 19;18(1):96

Click to viewLiterature interpretationReporter:Zhejiang University First Affiliated Hospital Pain Department, Shi Qinglu

Research

Background

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

Postherpetic neuralgia (PHN) is a devastating complication following varicella-zoster virus infection. It has been shown that brain-derived neurotrophic factor (BDNF) is involved in the pathogenesis of PHN.

T1 is an isoform of the Tropomyosin receptor kinase B (TrkB) receptor, which is a high-affinity receptor for BDNF. It is upregulated in various neural injuries and is associated with pain. Acid-sensing ion channel protein 3 (ASIC3) is involved in chronic neuropathic pain, but its relationship with peripheral nervous system BDNF/TrkB.T1 remains unclear.

This study aims to investigate whether BDNF/TrkB.T1 participates in the occurrence of PHN by regulating ASIC3 signaling in dorsal root ganglia (DRGs).

Methods

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

Establishment of PHN Rat Model

Rats in the RTX group were anesthetized with isoflurane inhalation (2% isoflurane in a mixture of oxygen and air) followed by intraperitoneal injection of RTX (200μg/k). RTX was dissolved in physiological saline containing 10% Tween 80 and 10% ethanol.

RTX

Resiniferatoxin (RTX) is a super potent analog of capsaicin. Intraperitoneal injection of RTX reduced the thermal sensitivity of rats and increased their sensitivity to tactile stimulation.

Results

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

Inhibition of BDNF/TrkB.T1 alleviates RTX-induced postherpetic neuralgia by decreasing ASIC3 signaling in dorsal root ganglia.

Experimental Summary

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

1. RTX promotes the expression of ASIC3 and TrkB.T1 in DRGs.

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic NeuralgiaInhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

2. Inhibition of ASIC3 alleviates mechanical pain and reduces TRAF6 signaling.

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

3. Inhibition of ASIC3 reduces the hyperexcitability of DRG neurons.

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

4. Inhibition of TrkB.T1 alleviates mechanical pain and reduces ASIC3 signaling.

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic NeuralgiaInhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic NeuralgiaInhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

5. Inhibition of TrkB.T1 increases the hyperexcitability of DRG neurons.

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

6. The TrkB.T1 receptor participates in RTX-PHN through ASIC3 signaling.

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

7. Intraperitoneal injection of RTX increases BDNF expression in DRGs.

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

8. Exogenous BDNF enhances PC-12 cell TrkB.T1-ASIC3 signaling.

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

9. ASIC3 knockdown inhibited TRAF6 signaling activation induced by exogenous BDNF in PC-12 cells.

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic NeuralgiaInhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

Discussion

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

Conclusion

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

This study suggests that inhibiting BDNF/TrkB.T1 can alleviate RTX-induced mechanical allodynia by regulating ASIC3 signaling, reducing inflammatory factor levels, and reversing the hyperexcitability of DRG neurons, providing a potential new therapeutic target for the prevention and treatment of PHN.

END

Inhibiting BDNF/TrkB.T1 Receptor Alleviates Postherpetic Neuralgia

Zhejiang University First Affiliated Hospital Pain Department

Leave a Comment